Designed in the UK and engineered in Korea, EOS-X features the brand’s iconic hard-shell delivery system of high-concentration light-emitting diodes in a proximity design that is five times more efficient than non- contact ‘canopy’ methods.
Distributed and owned by Harpar Grace International, EOS-X will launch simultaneously in the UK and USA, ahead of a more comprehensive European roll-out in the summer.
The mask features feature 1070nm wavelength technology, clinically proven to penetrate deeper into the subcutaneous tissue and muscle, prompting a bio-stimulatory effect on ageing and compromised tissue while improving microcirculation and cellular oxygenation. The combined application of three wavelengths in the anti-ageing medical mode of EOS-X is designed to elicit synergistic immune responses within the body that are completely painless.
The new model integrates FDA-approved medical efficacy with holistic wellbeing, supporting patient demand for treatments that balance skincare outcomes with overall wellness and vitality.
Chief executive Alana Chalmers comments “Our new technology equips the practitioner with the capability to unlock the most extensive range of wavelengths in the market for aesthetic and wellbeing applications. Coupled with our at- home devices, the Déesse PRO portfolio unlocks unrivalled integration and treatment journeys that are commercially progressive and a must for the future needs of our practitioners and their patients”.
